Cystic fibrosis: A multiple exocrinopathy caused by dysfunctions in a multifunctional transport protein

American Journal of Medicine

Volumn 104, Issue 6, 1998, Pages 576-590

  Schwiebert, Erik M ^a   Benos, Dale J ^a   Fuller, Catherine M ^a,b  

^a UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^b UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ABC TRANSPORTER; CARRIER PROTEIN; CHLORIDE CHANNEL; DEFENSIN; DORNASE ALFA; GELSOLIN; IBUPROFEN; RECOMBINANT PROTEIN; REGULATOR PROTEIN; TRANSMEMBRANE CONDUCTANCE REGULATOR;

CLINICAL TRIAL; CYSTIC FIBROSIS; DISEASE SEVERITY; GENE MUTATION; GENE THERAPY; HUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN STRUCTURE; REGULATORY MECHANISM; RESPIRATORY TRACT DISEASE; RESPIRATORY TRACT INFECTION; REVIEW;

EID: 0032104299     PISSN: 00029343     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9343(98)00119-3     Document Type: Article

References (123)

1. 1. Riordan JR, Rommens JM, Kerem B, et al. Identification of the cystic fibrosis gene: cloning and characterization of complementary DNA. Science. 1989;245:1066-1073.
2. 2. Rommens JM, Iannuzzi MC, Kerem B-S, et al. Identification of the cystic fibrosis gene: chromosome walking and jumping. Science. 1989;245:1059-1065.
3. 3. Welsh MJ, Smith AE. Molecular mechanisms of CFTR chloride channel dysfunction in CF. Cell. 1993;73:1251-1254.
4. 4. Collins FS. Cystic fibrosis: molecular biology and therapeutic implications. Science. 1992;256:774-779.
5. 5. Welsh MJ. Electrolyte transport by airway epithelia. Physiol Rev. 1987;67:1143-1183.
6. 6. O'Brodovich H. Epithelial ion transport in the fetal and perinatal lung. Am J Physiol (Cell Physiol). 1991;261:C555-C564.
7. 7. Ramsey BW. Management of pulmonary disease in patients with cystic fibrosis. NEJM. 1996;335:179-188.
8. 8. Higgins CF. The ABC of channel regulation. Cell. 1995;82:693-696.
9. 9. Higgins CF. ABC transporters: from microorganisms to man. Annu Rev Cell Biol. 1992;8:67-113.
10. 10. Gottesman MM, Pastan I, Ambudkar SV. P-glycoprotein and multidrug resistance. Curr Opin Genet Dev. 1996;6:610-617.
11. 11. Gottesman MM, Hrycyna CA, Schoenlein PV, et al. Genetic analysis of the multidrug transporter. Ann Rev Genet. 1995;29:607-649.
12. 12. van Helvoort A, Smith AJ, Sprong H, et al. mdr1 P-glycoprotein is a lipid translocase of broad specificity, while mdr3 P-glycoprotein specifically translocates phosphatidylcholine. Cell. 1996;87:507-517.
13. 4 transport by co-expression of both half molecules of human multidrug resistance protein in insect cells. J Biol Ghent. 1996;271:27782-27787.
14. 14. Aguilar-Bryan L, Nichols CG, Wechsler SW, et al. Cloning of the β cell high affinity sulfonylurea receptor: a regulator of insulin secretion. Science. 1995;268:423-426.
15. + channels. Neuron. 1996;16:1011-1017.
16. 16. Thomas PM, Cote GJ, Wohlik N, et al. Mutations in the sulfonylurea receptor gene in familial persistent hyperinsulinemic hypoglycemia of infancy. Science. 1995;268:426-429.
17. 17. Kelly A, Powis SH, Kerr LA, et al. Assembly and function of the two ABC transporters encoded in the human major histocompatibility complex. Nature. 1992;355:641-644.
18. 18. Donato L, de la Salle D, Hanau D, et al. Association of HLA class I antigen deficiency related to a TAP2 gene mutation with familial bronchiectasis. J Pediatr. 1995;127:895-900.
19. 19. Mosser J, Douar A-M, Sarde C-O, et al. Putative X-linked adrenoleukodystrophy gene shares unexpected homology with ABC transporters. Nature. 1993;361:726-730.
20. 20. Fanen P, Guidoux S, Sarde C-O, et al. Identification of mutations in the putative ATP-binding domain of the adrenoleukodystrophy gene. J Clin Invest. 1994;94:516-520.
21. 21. van Kuijck MA, van Aubel RAMH, Busch AE, et al. Molecular cloning and expression of a cyclic AMP-activated chloride conductance regulator: a novel ATP-binding cassette transporter. Proc Natl Acad Sci USA. 1996;93:5401-5406.
22. 22. Welsh MJ, Anderson MP, Rich DP, et al. Cystic fibrosis transmembrane conductance regulator: a chloride channel with novel regulation. Neuron. 1992;8:821-829.
23. - channel in CHO cells stably expressing the cystic fibrosis gene. Nature. 1991;352:628-631.
24. 24. Jia Y, Mathews CJ, Hanrahan JW. Phosphorylation by protein kinase C is required for acute activation of cystic fibrosis transmembrane conductance regulator by protein kinase A. J Biol Chem. 1997;272:4978-4984.
25. 25. Schwiebert EM, Benos DJ, Egan ME, et al. CFTR is a "conductance regulator" as well as a chloride channel. Physiol Rev. 1998; in press.
26. 26. Schwiebert EM, Egan ME, Hwang T-H, et al. CFTR regulates outwardly rectifying chloride channels through an autocrine mechanism involving ATP. Cell. 1995;81:1063-1073.
27. 27. Bijman J, Quinton PM. Permeability properties of cell membranes and tight junctions of normal and cystic fibrosis sweat ducts. Pflugers Arch. 1987;408:505-510.
28. 28. Schwiebert EM, Lopes AG, Guggino WB. Chloride channels along the nephron. In: Guggino WB, ed. Chloride Channels. San Diego: Academic Press; 1994:265-315.
29. 29. Schwiebert EM, Guggino WB. Abnormal chloride and sodium channel function in cystic fibrosis airway epithelia. In: Crystal RG, Barnes PJ, West JB, Weibel ER, eds. The Lung: Scientific Foundations. New York: Lippincott-Raven; 1997:2555-2572.
30. 30. Morales MM, Carroll TP, Morita T, et al. Both wild-type and a functional isoform of CFTR are expressed in kidney. Am J Physiol (Renal, Fluid, Electrolyte Physiol). 1996;270:F1038-F1048.
31. 31. Riordan JR, Chang X-B. CFTR, a channel with the structure of a transporter. Biochim Biophys Acta. 1992;1101:221-222.
32. - channel activity in Xenopus oocytes expressing the cystic fibrosis gene. J Biol Chem. 1991;266:19142-19145.
33. 33. Drumm ML, Pope HA, Cliff WH, et al. Correction of the cystic fibrosis defect in vitro by retrovirus-mediated gene transfer. Cell. 1990;62:1227-1233.
34. 34. Anderson MP, Rich DP, Gregory RJ, et al. Generation of cAMP-activated chloride currents by expression of CFTR. Science. 1991; 251:679-682.
35. 35. Tilly BC, Winter MC, Ostedgaard LS, et al. Cyclic AMP-dependent protein kinase activation of cystic fibrosis transmembrane conductance regulator chloride channels in planar lipid bilayers. J Biol Chem. 1992;267:9470-9473.
36. 36. Bear CE, Li C, Kartner N, et al. Purification and functional reconstitution of the cystic fibrosis transmembrane conductance regulator (CFTR). Cell. 1992;68:809-818.
37. 37. Berger HA, Anderson MP, Gregory RJ, et al. Identification and regulation of the cystic fibrosis transmembrane conductance regulator-generated chloride channel. J Clin Invest. 1991;88:1422-1431.
38. 38. Anderson MP, Berger HA, Rich DP, et al. Nucleoside triphosphates are required to open the CFTR chloride channel. Cell. 1991; 67:775-784.
39. 39. Li M, McCann JD, Liedtke CM, et al. Cyclic AMP-dependent protein kinase opens chloride channels in normal but not cystic fibrosis airway epithelium. Nature. 1988;331:358-360.
40. 40. Schoumacher RA, Shoemaker RL, Halm DR, et al. Phosphorylation fails to activate chloride channels from cystic fibrosis airway cells. Nature. 1987;330:752-754.
41. 41. Hwang T-C, Lu L, Zeitlin, PL, et al. Chloride channels in CF: lack of activation by protein kinase C and cAMP-dependent protein kinase. Science. 1989;244:1351-1353.
42. - channels in undifferentiated human colonic cells (HT-29). I. Single-channel properties. Am J Physiol (Cell Physiol). 1993;264:C968-C976.
43. 43. Jentsch TJ. Molecular physiology of chloride channels. Curr Opin Cell Biol. 1994;6:600-606.
44. 44. Pusch M, Jentsch TJ. Molecular physiology of voltage-gated chloride channels. Physiol Rev. 1994;74:813-827.
45. 45. Jentsch TJ, Gunther W. Chloride channels: an emerging molecular picture. BioEssays. 1997;19:117-126.
46. - channels by protein kinase A corrected by insertion of CFTR. Nature. 1992;358:581-584.
47. 47. Gabriel SE, Clarke LL, Boucher RC, Stutts MJ. CFTR and outwardly rectifying chloride channels are distinct proteins with a regulatory relationship. Nature. 1993;363:263-268.
48. 48. Jovov B, Ismailov II, Benos DJ. Cystic fibrosis transmembrane conductance regulator is required for protein kinase activation of an outwardly rectified anion channel purified from bovine tracheal epithelia. J Biol Chem. 1995;270:1521-1528.
49. 49. Hwang TH, Schwiebert EM, Guggino WB. Apical and basolateral ATP stimulate tracheal epithelial chloride secretion via multiple purinergic receptors and signaling pathways. Am J Physiol (Cell Physiol). 1996;270:C1611-C1623.
50. 50. Jovov B, Ismailov II, Berdiev BK, et al. Interaction between cystic fibrosis transmembrane conductance regulator and outwardly rectified chloride channels. J Biol Chem. 1995;270:29194-29200.
51. 51. Clarke LL, Grubb BR, Gabriel SE, et al. Defective epithelial chloride transport in a gene-targeted mouse model of cystic fibrosis. Science. 1992;257:1125-1128.
52. - secretion in nasal epithelia of CF mice. Am J Physiol (Cell Physiol). 1994;266:C1478-C1483.
53. 53. Grubb BR, Paradiso AM, Boucher RC. Anomalies in ion transport in CF mouse tracheal epithelium. Am J Physiol (Cell Physiol). 1994; 267:C293-C300.
54. 54. Knowles MR, Clarke LL, Boucher RC. Extracellular ATP and UTP induce chloride secretion in nasal epithelia of cystic fibrosis patients and normal subjects in vivo. Chest. 1992;101:60-63.
55. 55. Bennett WD, Olivier KN, Zeman KL, et al. Effect of uridine 5′-triphosphate plus amiloride on mucociliary clearance in adult cystic fibrosis. Am J Respir Crit Care Med. 1996;153:1796-1801.
56. + transport in cystic fibrosis epithelia. Abnormal basal rate and response to adenylate cyclase activation. J Clin Invest. 1986;78:1245-2152.
57. 57. Knowles MR, Stutts MJ, Spock A, et al. Abnormal ion permeation through cystic fibrosis respiratory epithelium. Science. 1983;221: 1067-1070.
58. 58. Canessa CM, Horisberger J-D, Rossier BC. Epithelial sodium channel related to proteins involved in neurodegradation. Nature. 1993;361:467-470.
59. + channel is made of three homologous subunits. Nature. 1994; 367:463-467.
60. 60. Canessa CM, Merillat AM, Rossier BC. Membrane topology of the epithelial sodium channel in intact cells. Am J Physiol (Cell Physiol). 1994;267:C1682-C1690.
61. + channels. Am J Physiol (Cell Physiol). 1993;264:L357-L364.
62. 62. Yue G, Russell WJ, Benos DJ, et al. Increased expression and activity of sodium channels in alveolar type II cells of hyperoxic rats. Proc Natl Acad Sci USA 1995;92:8418-8422.
63. 63. Chinet TC, Fullton JM, Yankaskas JR, et al. Mechanism of sodium hyperabsorption in cultured cystic fibrosis nasal epithelium: a patch-clamp study. Am J Physiol (Cell Physiol). 1994;266:C1061-C1068.
64. 64. Duszyk M, French AS, Man SFP. Cystic fibrosis affects chloride and sodium channels in human airway epithelia. Can J Physiol Pharmacol. 1989;67:1362-1365.
65. + channel in the developing rat lung. Am J Physiol (Cell Physiol). 1993;265:C491-C496.
66. + channel by steroid hormones. EMBO J. 1994;13:2177-2181.
67. + channels: function and diversity. Annu Rev Physiol. 1992;54:51-66.
68. 68. Schwiebert EM, Potter ED, Hwang T-H, et al. Cyclic nucleotide-gated chloride and sodium currents in rat tracheal airway epithelium. Am J Physiol (Cell Physiol). 1997;272:C911-C922.
69. 69. Johnson LG, Boyles SE, Wilson JM, Boucher RC. Normalization of raised sodium absorption and raised calcium-mediated chloride secretion by adenovirus-mediated expression of cystic fibrosis transmembrane conductance regulator in primary human cystic fibrosis airway epithelia cells. J Clin Invest. 1995;95:1377-1382.
70. 70. Stutts MJ, Canessa CM, Olsen JC, et al. CFTR as a cAMP-dependent regulator of sodium channels. Science. 1995;269:847-850.
71. 71. Berdiev BK, Prat AG, Cantiello HF, et al. Regulation of epithelial sodium channels by short actin filaments. J Biol Chem. 1996;271: 17704-17710.
72. 72. Ismailov II, Awayda MS, Jovov B, et al. Regulation of epithelial sodium channels by the cystic fibrosis transmembrane conductance regulator. J Biol Chem. 1996;271:4725-4732.
73. 73. Ismailov II, Berdiev BK, Shlyonsky VG, et al. Role of actin in regulation of epithelial sodium channels by CFTR. Am J Physiol (Cell Physiol). 1997;272:C1077-C1086.
74. + currents by intracellular domains of the cystic fibrosis transmembrane conductance regulator. FEBS Lett. 1997; 400:341-344.
75. 75. Knowles MR, Buntin WH, Bromberg PA, et al. Measurements of transepithelial electric potential differences in the trachea and bronchi of human subjects in vivo. Am Rev Respir Dis. 1982;126: 108-112.
76. 76. Barasch J, Kiss B, Prince A, et al. Defective acidification of intracellular organelles in cystic fibrosis. Nature. 1991;352:70-73.
77. 77. Barasch J, Al-Awqati Q. Defective acidification of the biosynthetic pathway in cystic fibrosis. J Cell Sci. 1993;17:229-233.
78. 78. Bradbury NA, Jilling T, Berta G, et al. Regulation of plasma membrane recycling by CFTR. Science. 1992;256:530-532.
79. 79. Bradbury NA, Jilling T, Kirk KL, Bridges RJ. Regulated endocytosis in a chloride secretory epithelial cell lines. Am J Physiol (Cell Physiol). 1992;262:C752-C759.
80. 80. Schwiebert EM, Gesek F, Ercolani L, et al. Heterotrimeric G proteins, vesicle trafficking, and CFTR chloride channels. Am J Physiol (Cell Physiol). 1994;267:C272-C281.
81. 81. Imundo L, Barasch J, Prince A, Al-Awqati Q. Cystic fibrosis epithelial cells have a receptor for pathogenic bacteria on their apical surface. Proc Natl Acad Sci USA. 1995;92:3019-3025.
82. 82. Thomas PJ, Pedersen PL. Effects of the deltaF508 mutation on the structure, function, and folding of the first nucleotide-binding domain of CFTR. J Bioenerg Biomembr. 1993;25:11-19.
83. 83. Thomas PJ, Qu B-H, Pedersen PL. Defective protein folding as a basis of human disease. Trends Biochem Sci. 1995;20:456-459.
84. 84. Cutting GR, Kasch LM, Rosenstein BJ, et al. A cluster of cystic fibrosis mutations in the first nucleotide-binding fold of the cystic fibrosis transmembrane conductance regulator protein. Nature. 1990;346:366-369.
85. 85. McIntosh I, Cutting GR. Cystic fibrosis transmembrane conductance regulator and the etiology and pathogenesis of cystic fibrosis. FASEB J 1992;6:2775-2782.
86. 86. Hamosh A, Rosenstein BJ, Cutting GR. CFTR nonsense mutations G542X and W1282X associated with severe reduction in CFTR mRNA in nasal epithelial cells. Hum Mol Genet. 1992;1:542-544.
87. 87. Hamosh A, Trapnell BC, Zeitlin PL, et al. Severe deficiency in cystic fibrosis transmembrane conductance regulator messenger RNA carrying nonsense mutations R553X and W1316X in respiratory epithelial cells of patients with cystic fibrosis. J Clin Invest. 1991;88:1880-1885.
88. 88. Fulmer SB, Schwiebert EM, Morales MM, et al. Two cystic fibrosis transmembrane conductance regulator mutations have different effects on both pulmonary phenotype and regulation of outwardly rectified chloride currents. Proc Natl Acad Sci USA. 1995;92:6832-6836.
89. 89. Smit LS, Wilkinson DJ, Mansoura MK, et al. Functional roles of the nucleotide-binding folds in the activation of the cystic fibrosis transmembrane conductance regulator. Proc Natl Acad Sci USA. 1993;90:9963-9967.
90. 90. Drumm ML, Wilkinson DJ, Smit L, et al. Chloride channels expressed by delF508 and other mutant CFTRs in Xenopus oocytes. Science. 1991;254:1797-1799.
91. 91. Curtis A, Nelson R, Porteous M, et al. Association of less common cystic fibrosis mutations with a mild phenotype. J Med Genet. 1991;28:34-37.
92. 92. Parad RB. Heterogeneity of phenotype in two cystic fibrosis patients homozygous for the CFTR exon 11 mutation G551D. J Med Genet. 1996;33:711-713.
93. 93. Delaney SJ, Alton EW, Smith SN, et al. Cystic fibrosis mice carrying the missense mutation G551D replicate human genotype-phenotype correlations. J Med Genet. 1996;15:955-963.
94. 94. Piazza-Carroll T, McIntosh I, Egan ME, et al. Transmembrane mutations alter the channel characteristics of the cystic fibrosis transmembrane conductance regulator expressed in Xenopus oocytes. Cell Physiol Biochem. 1994;4:10-18.
95. 95. Oates RD, Amos JA. The genetic basis of congenital bilateral absence of the vas deferens and cystic fibrosis. J Androl. 1994;15:1-8.
96. 96. Wilschanski M, Corey M, Durie P, et al. Diversity of reproductive tract abnormalities in men with cystic fibrosis. JAMA. 1996;276: 607-608.
97. - channels with altered pore properties. Nature. 1993;362:160-164.
98. 98. Tabcharani JA, Rommens JM, Hou Y-X, et al. Multi-ion pore behaviour in the CFTR chloride channel. Nature. 1993;366:79-82.
99. 99. Mansoura MK, Strong TV, Collins FS, Dawson DC. A disease-related mutation in the fifth putative transmembrane segments alters the conduction and gating properties of CFTR. J Gen Physiol. 1994;104:36a. Abstract.
100. 100. Seibert FS, Linsdell P, Loo TW, et al. Disease-associated mutations in the fourth cytoplasmic loop of cystic fibrosis transmembrane conductance regulator compromise biosynthetic processing and chloride channel activity. JBiol Chem. 1996;271:15139-15145.
101. 101. Cheng SH, Rich DP, Marshall J, et al. Phosphorylation of the R domain by cAMP-dependent protein kinase regulates the CFTR chloride channel. Cell. 1991;66:1027-1036.
102. 102. Rich DP, Gregory RJ, Anderson MP, et al. Effect of deleting the R domain on CFTR-generated chloride channels. Science. 1991;253: 205-207.
103. 103. Chang X-B, Tabcharani JA, Hou Y-X, et al. Protein kinase A (PKA) still activates CFTR chloride channel after mutagenesis of all 10 PKA consensus phosphorylation sites. J Biol Chem. 1993; 268:11304-11311.
104. 104. Ramsey BW, Astley SJ, Aitken ML, et al. Efficacy and safety of short-term administration of aerosolized recombinant human deoxyribonuclease in patients with cystic fibrosis. Am Rev Respir Dis. 1993;148:145-151.
105. 105. Vasconcellos CA, Allen PG, Wohl ME, et al. Reduction of viscosity of cystic fibrosis sputum in vitro by gelsolin. Science. 1994;263: 969-971.
106. 106. Konstan MW, Byard PJ, Hoppel CL, Davis PB. Effect of high dose ibuprofen in patients with cystic fibrosis. NEJM. 1995;332:848-854.
107. 107. Smith JJ, Travis SM, Greenberg EP, Welsh MJ. Cystic fibrosis airway epithelia fail to kill bacteria because of abnormal airway surface fluid. Cell. 1996;85:229-236.
108. 108. Wine JJ. A sensitive defense: salt and cystic fibrosis. Nature Med. 1997;3:494-495.
109. 109. McCray PB, Bentley L. Human airway epithelia express a β-defensin. Am J Resp Cell Mol Biol. 1997;16:343-349.
110. 110. Goldman MJ, Anderson GM, Stolzenberg ED, et al. Human β-defensin-1 is a salt-sensitive antibiotic in lung that is inactivated in cystic fibrosis. Cell. 1997;88:553-560.
111. 111. Denning GM, Anderson MP, Amara JF, et al. Processing of mutant cystic fibrosis transmembrane conductance regulator is temperature sensitive. Nature. 1992;358:761-764.
112. 112. Ward CL, Omura S, Kopito RR. Degradation of CFTR by the ubiquitin-proteasome pathway. Cell. 1995;83:121-127.
113. 113. Jensen TJ, Loo MA, Pind S, et al. Multiple proteolytic systems, including the proteasome, contribute to CFTR processing. Cell. 1995;83:129-135.
114. 114. Rubenstein RC, Brusilow SW, Hamosh A, Zeitlin PL. Clinical trials of 4-phenylbutyrate for correction of sweat duct abnormalities in delF508 homozygous cystic fibrosis patients. Ped Pulmonol 1996;13:259.
115. 115. Howard M, Frizzell RA, Bedwell DM. Aminoglycoside antibiotics restore CFTR function by overcoming premature stop codon mutations. Nature Med. 1996;2:467-469.
116. 116. Knowles MR. Pharmacologic treatment of abnormal ion transport in the airway epithelium in cystic fibrosis. Chest. 1995;107:71S-76S.
117. 117. Jones KM, Liao E, Hohneker KW, et al. Pharmacokinetics of amiloride after inhalation and oral administration in adolescents and adults with cystic fibrosis. Pharmacotherapy. 1997;17:263-270.
118. 118. Knowles MR, Church NL, Waltner WE, et al. A pilot study of aerosolized amiloride for the treatment of lung disease in cystic fibrosis. NEJM. 1990;322:1189-1194.
119. 119. Wilson JM. Gene therapy for cystic fibrosis: challenges and future directions. J Clin Invest. 1995;96:2547-2554.
120. 120. Taglicht D, Michaelis S. A complete catalogue of Saccharomyces cerevisiae ABC proteins and their relevance to human health and disease. In: Ambudkar SV, Gottesman MM, eds. ABC Transporters: Biochemical, Cellular, and Molecular Aspects. Methods in Enzymology, Volume 292, San Diego, California: Academic Press, 1998.
121. 121. Higgins CF, Hiles ID, Salmond GPC, et al. A family of related ATP-binding subunits coupled to many distinct biological processes in bacteria. Nature. 1986;323:448-450.
122. + channels (ROMK2) to the inhibitory sulfonylurea compound, glibenclamide, is enhanced by co-expression with the ATP-binding cassette transporter CFTR. Proc Natl Acad Sci USA. 1996;93:8083-8088.
123. 123. McNicholas CM, Nason MW, Guggino WB, et al. Sulfonylurea sensitivity of ROMK2 is altered by coexpression with full length and truncated forms of CFTR. J Am Soc Neph. 1996;7:1286.